BMAL1 and neoplasm: Our results showed that BMAL1 KD led to a significant reduction in proliferation (~40% reduction, p = 0.0007), induction of apoptosis (1.4-fold induction, p = 0.0152) accompanied by a reduction of tumour size (30% reduction, p = 0.0003).